Meghan Scanlon

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Marlborough, MA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Robert McCormack, as Attorney-in-Fact for Meghan Scanlon
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Meghan Scanlon

Form 4 holding SVP,Pres,Urology Pelvic Health

BOSTON SCIENTIFIC CORP

Security class
Common Stock
Shares / value
24,461
Estimated value
$1,467,660
Report date
01 May 2022
Price
$60.00
Ownership
Direct
Form 4 holding SVP,Pres,Urology Pelvic Health

BOSTON SCIENTIFIC CORP

Security class
Deferred Stock Units
Shares / value
2,062
Estimated value
$111,472
Report date
01 May 2022
Price
$54.06
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Meghan Scanlon

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .